艾昆纬- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于艾昆纬公司

IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.

艾昆纬简介



公司代码IQV

公司名称IQVIA Holdings Inc

上市日期May 09, 2013

CEOBousbib (Ari)

员工数量88000

证券类型Ordinary Share

年结日May 09

公司地址2400 Ellis Road

城市DURHAM

上市交易所NASDAQ OMX NASDAQ Basic NYSE

国家United States of America

邮编27703

电话19199982000

网址https://ir.iqvia.com/

公司代码IQV

上市日期May 09, 2013

CEOBousbib (Ari)

艾昆纬公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.41M

+2.04%

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

65.53K

+14.55%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

30.89K

+15.83%

Mr. John G. Danhakl

Independent Director

30.32K

+5.25%

Dr. John M. Leonard, M.D.

Lead Independent Director

16.95K

+9.27%

Ms. Colleen A. Goggins

Independent Director

14.45K

+10.87%

Ms. Carol J. Burt

Independent Director

5.96K

--

Mr. Bhavik Patel

President, Commercial Solutions

3.03K

+71.48%

Mr. James A. Fasano

Independent Director

1.06K

--

Mr. John P. Connaughton

Independent Director

1.05K

--

名称

名称/职务

职务

持股

持股变动

Mr. Ari Bousbib

Chairman of the Board, Chief Executive Officer

1.41M

+2.04%

Mr. Ronald E. (Ron) Bruehlman

Chief Financial Officer, Executive Vice President

65.53K

+14.55%

Mr. Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

30.89K

+15.83%

Mr. John G. Danhakl

Independent Director

30.32K

+5.25%

Dr. John M. Leonard, M.D.

Lead Independent Director

16.95K

+9.27%

Ms. Colleen A. Goggins

Independent Director

14.45K

+10.87%

收入明细

单位: USD更新时间: 4月6日周一

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

由于公司未披露，未能获取相关数据

地区USD

名称

营收

占比

Americas

7.75B

47.49%

Europe & Africa Region

5.18B

31.79%

Asia Pacific Region

3.38B

20.72%

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 5月10日周日

持股股东

股东类型

持股股东

占比

Harris Associates L.P.

6.78%

Vanguard Capital Management, LLC

6.61%

BlackRock Institutional Trust Company, N.A.

5.19%

Vanguard Portfolio Management, LLC

4.54%

State Street Investment Management (US)

4.46%

其他

72.42%

持股股东

占比

Harris Associates L.P.

6.78%

Vanguard Capital Management, LLC

6.61%

BlackRock Institutional Trust Company, N.A.

5.19%

Vanguard Portfolio Management, LLC

4.54%

State Street Investment Management (US)

4.46%

其他

72.42%

股东类型

持股股东

占比

Investment Advisor

48.99%

Investment Advisor/Hedge Fund

38.83%

Sovereign Wealth Fund

5.32%

Hedge Fund

2.94%

Pension Fund

2.82%

Research Firm

2.77%

Bank and Trust

2.23%

Individual Investor

1.00%

Family Office

0.16%

机构持股



更新时间: 4月5日周日

报告期

机构数

持股数

持股占比

持股变动

2026Q1

2209

173.06M

103.69%

-9.60M

2025Q4

2132

171.19M

100.94%

-15.17M

2025Q3

2061

175.98M

103.33%

-829.63K

2025Q2

2053

166.70M

98.05%

-9.45M

2025Q1

2083

168.53M

97.38%

-9.36M

2024Q4

2059

171.87M

97.45%

+3.00M

2024Q3

2008

173.01M

95.44%

+863.78K

2024Q2

1977

164.85M

90.43%

-7.68M

2024Q1

1950

165.50M

90.84%

-10.38M

2023Q4

1948

168.90M

93.03%

-6.38M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Harris Associates L.P.

11.32M

6.74%

-67.55K

-0.59%

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

8.67M

5.16%

-772.77K

-8.18%

Dec 31, 2025

State Street Investment Management (US)

7.45M

4.44%

-102.01K

-1.35%

Dec 31, 2025

GIC Private Limited

6.54M

3.9%

-2.59M

-28.36%

Mar 31, 2025

Geode Capital Management, L.L.C.

4.37M

2.61%

+24.45K

+0.56%

Dec 31, 2025

Boston Partners

4.09M

2.43%

+530.67K

+14.92%

Dec 31, 2025

Artisan Partners Limited Partnership

3.37M

2.01%

-62.57K

-1.82%

Dec 31, 2025

AllianceBernstein L.P.

3.30M

1.97%

-293.54K

-8.16%

Dec 31, 2025

持股ETF



更新时间: 12月2日周二

机构名称

占比

First Trust Nasdaq Lux Digi Health Solutions ETF

9.1%

Langar Global HealthTech ETF

7.83%

Global X HealthTech ETF

5.5%

VanEck Biotech ETF

4.98%

iShares Biotechnology ETF

3.23%

iShares Health Innovation Active ETF

3.05%

Adaptive Core ETF

3.04%

Invesco Bloomberg Pricing Power ETF

2.24%

Running Oak Efficient Growth ETF

2.16%

Invesco Zacks Mid-Cap ETF

2.08%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比9.1%

Langar Global HealthTech ETF

占比7.83%

Global X HealthTech ETF

占比5.5%

VanEck Biotech ETF

占比4.98%

iShares Biotechnology ETF

占比3.23%

iShares Health Innovation Active ETF

占比3.05%

Adaptive Core ETF

占比3.04%

Invesco Bloomberg Pricing Power ETF

占比2.24%

Running Oak Efficient Growth ETF

占比2.16%

Invesco Zacks Mid-Cap ETF

占比2.08%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

除权除息日

类型

比率

暂无数据

公告日期

除权除息日

类型

比率

暂无数据

艾昆纬

关于 艾昆纬 公司

艾昆纬简介

艾昆纬公司高管

收入明细

股东统计

机构持股

股东持股明细

持股ETF

分红派息

拆合股

关于艾昆纬公司